|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
44,500,000 |
Market
Cap: |
208.71(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$4.39 - $22.2 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile uniQure is engaged in the field of gene therapy, focusing to develop single treatments for patients suffering from genetic and other diseases. Co. is developing etranacogene dezaparvovec, a gene therapy for patients with hemophilia B that is designed to restore Factor IX (FIX) activity, a protein for blood clotting. Etranacogene dezaparvovec includes an adeno-associated virus (AAV) 5 vector incorporating the FIX-Padua variant. Co. is also developing AMT-180 for hemophilia A, AMT-190 for fabry disease, and AMT-130 for huntington's disease. Co.'s AMT-150 is a one-time, intrathecally-administered, AAV gene therapy incorporating Co.'s miQURE silencing technology.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
53,265 |
53,265 |
74,223 |
229,905 |
Total Sell Value |
$339,844 |
$339,844 |
$555,147 |
$3,944,931 |
Total People Sold |
3 |
3 |
4 |
13 |
Total Sell Transactions |
3 |
3 |
5 |
43 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kapusta Matthew C |
CEO, CFO, Managing Director |
|
2022-01-26 |
4 |
S |
$18.10 |
$197,308 |
D/D |
(10,901) |
245,676 |
|
16% |
|
Klemt Christian |
Chief Financial Officer |
|
2022-01-26 |
4 |
S |
$18.03 |
$71,453 |
D/D |
(3,963) |
66,820 |
|
16% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2022-01-26 |
4 |
S |
$18.02 |
$53,069 |
D/D |
(2,945) |
63,697 |
|
16% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-12-15 |
4 |
AS |
$27.90 |
$167,400 |
D/D |
(6,000) |
66,642 |
|
-47% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-12-15 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
72,642 |
|
- |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-10-15 |
4 |
AS |
$30.65 |
$183,900 |
D/D |
(6,000) |
66,642 |
|
-43% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-10-15 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
72,642 |
|
- |
|
Klemt Christian |
Chief Financial Officer |
|
2021-09-21 |
4 |
AS |
$38.00 |
$91,200 |
D/D |
(2,400) |
70,783 |
|
-52% |
|
Gut Robert |
Director |
|
2021-09-21 |
4 |
S |
$36.61 |
$164,745 |
D/D |
(4,500) |
37,501 |
|
52% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-09-21 |
4 |
S |
$36.71 |
$81,827 |
D/D |
(2,229) |
66,642 |
|
52% |
|
Dolmetsch Ricardo |
President, R&D |
|
2021-09-16 |
4 |
S |
$37.10 |
$319,171 |
D/D |
(8,603) |
69,126 |
|
55% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-09-15 |
4 |
AS |
$36.32 |
$217,920 |
D/D |
(6,000) |
68,871 |
|
-52% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-09-15 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
74,871 |
|
- |
|
Kapusta Matthew C |
CEO, CFO, Managing Director |
|
2021-08-18 |
4 |
AS |
$28.08 |
$28,146 |
D/D |
(1,000) |
256,577 |
|
-26% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-08-16 |
4 |
AS |
$28.84 |
$173,040 |
D/D |
(6,000) |
68,871 |
|
-25% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-08-16 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
74,871 |
|
- |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-07-15 |
4 |
AS |
$27.22 |
$163,320 |
D/D |
(6,000) |
68,871 |
|
9% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-07-15 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
74,871 |
|
- |
|
Kapusta Matthew C |
CEO, CFO, Managing Director |
|
2021-07-14 |
4 |
AS |
$27.77 |
$27,770 |
D/D |
(1,000) |
257,577 |
|
6% |
|
Kapusta Matthew C |
CEO, CFO, Managing Director |
|
2021-06-17 |
4 |
AS |
$35.00 |
$66,500 |
D/D |
(1,900) |
258,577 |
|
-15% |
|
Kapusta Matthew C |
CEO, CFO, Managing Director |
|
2021-06-16 |
4 |
AS |
$34.26 |
$119,453 |
D/D |
(3,450) |
260,477 |
|
-17% |
|
Klemt Christian |
Chief Financial Officer |
|
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,579 |
73,183 |
|
- |
|
Caloz Pierre |
Chief Operating Officer |
|
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
|
- |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-06-15 |
4 |
AS |
$35.43 |
$212,580 |
D/D |
(6,000) |
68,871 |
|
-18% |
|
Kuta Alexander Edward Iii |
Executive VP, Operations |
|
2021-06-15 |
4 |
OE |
$5.31 |
$31,860 |
D/D |
6,000 |
74,871 |
|
- |
|
336 Records found
|
|
Page 5 of 14 |
|
|